Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 12, 1996, Pages 2333-2341

  Bugge, Einar ^a   Ytrehus, Kirsti ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b NONE

Author keywords

Bradykinin; Chelerythrine; Hoe 140; Infarct size; Ischemic preconditioning; Nitric oxide; NOARG; Protein kinase C; Rat heart; TTC

Indexed keywords

ADENOSINE RECEPTOR; ALPHA ADRENERGIC RECEPTOR; BRADYKININ; BRADYKININ B2 RECEPTOR; CHELERYTHRINE; ICATIBANT; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FLUORESCENCE ANALYSIS; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

EID: 0030481419     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0226     Document Type: Article

References (34)

1. ARDELL JL, LIU Y, YANG X-M, COHEN MV, DOWNEY JM, 1995. Triggering of ischemic preconditioning involves bradykinin in in vivo but not in vitro rabbit hearts. (Abstract). J Mol Cell Cardiol 27: A44.
2. BAUMGARTEN CR, LINZ W, KUNKEL G, SCHOLKENS BA, WIEMER G, 1993. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmocol 108: 293-295.
3. BAYDOUN AR, WOODWARD B, 1991. Effects of bradykinin in the rat isolated perfused heart: role of kin in receptors and endothelium-derived relaxing factor. Br J Pharmacol 103: 1829-1833.
4. BREW EC, REHRING TF, BANERJEE A, 1994. Bradykinin receptors mediate preconditioning through protein kinase C. (Abstract). Circulation 90 [Suppl.]: I-207.
5. BUGGE E, YTREHUS K, 1995. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc Res 29: 401-406.
6. BUSSE R, FLEMING I, HECKER M, 1993. Signal transduction in endothelium-dependent vasodilatation. Eur Heart J 14 [Suppl. I]: 2-9.
7. DOWNEY JM, COHEN MV, YTREHUS K, LIU Y, 1994. Cellular mechanisms in ischemic preconditioning: The role of adenosine and protein kinase C. Ann NY Acad Sci 723: 82-98.
8. GOTO M, LIU Y, ARDELL JL, YANG X-M, COHEN MV, DOWNEY JM, 1995. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621.
9. HARTMAN JC, WALL TM, HULLINGER TG, SHEBUSKI RJ, 1993. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140. J Cardiovasc Pharmacol 21: 996-1003.
10. HERBERT JM, AUGEREAU JM, GLEYE J, MAFFRAND JP, 1990. Chelerythrine is a potent and specific inhibitor of protien kinase C. Biochem Biophys Res Commun 172: 993-999.
11. HOCK FJ, WIRTH K, ALBUS U, LINZ W, GERHARDS HJ, WIEMER G, HENKE S, BREIPOHL G, KONIG W, KNOWLE J, SCÖLKENS BA, 1991. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol 102: 769-773.
12. HOSHIDA S, KUZUYA T, NISHIDA M, YAMASHITA N, OE H, HORI M, KAMADA T, TADA M, 1994. Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts. Cardiovasc Res 28: 1083-1088.
13. ω-Nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol 176: 219-223.
14. KARMAZYN M, DHALLA NS, 1983. Physiological and pathophysiological aspects of cardiac prostaglandins. Can J Physiol Pharmacol 61: 1207-1225.
15. LI Y, KLONER RA, 1993. The cardioprotective effects of ischemic "preconditioning" are not mediated by adenosine receptors in rat hearts. Circulation 87: 1642-1648.
16. LINZ W, SCHÖLKENS BA, 1987. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts. J Cardiovasc Pharmacol 10 [Suppl. 7]: S75-S82.
17. 1 adenosine receptors in rabbit heart. Circulation 84: 350-356.
18. LIU Y, DOWNEY JM, 1992. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 263: H1107-H1112.
19. MARTORANA PA, KETTENBACH B, BREIPOHL G, LINZ W, SCHÖLKENS BA, 1990. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol 182: 395-396.
20. MARTORANA PA, LINZ W, SCHOLKENS BA, 1991. Does bradykinin play a role in the cardiac anti-ischemic effect of the ACE-inhibitors? Basic Res Cardiol 86: 293-296.
21. MIURA T, GOTO M, URABE K, ENDOH A, SHIMAMOTO K, IIMURA O, 1991. Does myocardial stunning contribute to infarct size limitation by ischemic preconditioning? Circulation 84: 2504-2512.
22. MURPHY E, GLASGOW W, FRALIX TA, STEENBERGEN C, 1995. Role of lipoxygenase metabolites in ischemic preconditioning. Circ Res 76: 457-467.
23. SCHROR K, 1992. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 20 [Suppl. 9]: S68-S73.
24. SCHULTZ JEJ, ROSE E, YAO Z, GROSS GJ, 1995. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 268: H2157-H2161.
25. SIEGFRIED MR, ERHARDT J, RIDER T, MA X-L, LEFER AM, 1992. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 260: 668-675.
26. TIO RA, TOBE TJ, BEL KJ, DE LANGEN CD, VAN GILST WH, WESSELING H, 1991. Beneficial effects of bradykinin on porcine ischemic myocardium. Basic Res Cardiol 86: 107-116.
27. TIPPMER S, QUITTERER U, KOLM V, FAUSSNER A, ROSCHER A, MOSTHAF L, MULLER ESTERL W, HARING H, 1994. Bradykinin induces translocation of the protein kinase C isoforms α, ε and ζ. Eur J Biochem 225: 297-304.
28. ATP channel. Am J Physiol 206: H829-H839.
29. VEGH A, SZEKERES L, PARRATT JR, 1991. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br J Pharmacol 104: 294-295.
30. 2 receptors. Br J Pharmacol 113: 1167-1172.
31. WALL TM, SHEEHY R, HARTMAN JC, 1994. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 290: 681-689.
32. WESELCOUCH EO, BAIRD AJ, SLEPH P, GROVER GJ, 1995. Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am J Physiol 268: H242-H249.
33. WEYRICH AS, MA X-L, LEFER AM, 1992. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86: 279-288.
34. WOOLFSON RG, PATEL VC, NEILD GH, YELLON DM, 1995. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91: 1545-1551.